| PUBCHEM ID |
45275360
|
| UNII |
CM3HYX69SK
|
| Preferred Term |
BRILACIDIN TETRAHYDROCHLORIDE
|
| CAS |
1224095-99-1
|
| INCHIKEY |
QTHBCQCKYVOFDR-PIJQHSLXSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
NC(N)=NCCCCC(Nc1cc(C(F)(F)F)cc(NC(c2cc(C(Nc(cc(C(F)(F)F)cc3NC(CCCCN=C(N)N)=O)c3O[C@@H]3CNCC3)=O)ncn2)=O)c1O[C@@H]1CNCC1)=O
|
| Total Surface Area |
679,64
|
| Relative PSA |
0,36337
|
| TPSA |
313,5
|
| cLogS |
-8,478
|
| MW |
936,917
|
| cLogP |
2,4744
|
| H-Acceptors |
20
|
| H-Donors |
10
|
| Ro5 violations |
3
|
| Druglikeness |
-8,1167
|
| DrugScore |
0,124663132521949
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
-0,0365
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,4041
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,4749
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,6549
|
| Carcinogenicity (Three-class) |
Non-required
|